Key result
Estradiol lowers blood pressure and vascular remodeling in hypertensive rats by promoting ERα-mediated GRK2 degradation.
Why the study?
Estradiol deficiency increases susceptibility to hypertension and vascular remodeling by mechanisms that remain unknown, particularly involving G protein-coupled receptor kinase 2 regulation.
Does estradiol supplementation reduce AngII-induced vascular remodeling and blood pressure in spontaneously hypertensive rats?
Does estradiol supplementation reduce AngII-induced vascular remodeling and blood pressure in spontaneously hypertensive rats?
Estradiol attenuates hypertensive vascular remodeling and lowers blood pressure in a rat model by inhibiting GRK2 and downregulating ERK signaling via ERα-mediated autophagy.
Answers are grounded in this paper and cite their sources.
Estradiol's vascular effects in estrogen-deficient hypertensive models warrant human studies; hypothesis-generating and should not yet change practice.
Hypertension acts as a critical cardiovascular risk factor that drives vascular remodeling, which manifests as vascular media thickening triggered by excessive proliferation and migration of vascular smooth muscle cells. Angiotensin II promotes vascular remodeling by upregulating G protein-coupled receptor kinase 2. Estradiol deficiency, particularly among postmenopausal individuals, increases susceptibility to hypertension by overactivating the renin-angiotensin system, while the precise mechanism remains unkown. Here we show that estradiol inhibits G protein-coupled receptor kinase 2 to ameliorate hypertensive vascular remodeling. Ovariectomy in spontaneously hypertensive rats exacerbate hypertension, while estradiol supplementation significantly reduced blood pressure and attenuated vascular remodeling. Mechanistically, Estradiol downregulated G protein-coupled receptor kinase 2 expression, leading to decreased β-arrestin2 recruitment and ERK signaling, thereby reducing vascular smooth muscle cell proliferation and migration. Additionally, Autophagy or estrogen receptor α blockade abolishes the effects of estradiol on G protein-coupled receptor kinase 2 degradation. This study provides a potential therapeutic strategy for hypertensive vascular remodeling. Ji and colleagues show that estradiol (E2) enhances autophagy and ERalpha-AMPK signaling in a mouse model of hypertension and vascular remodeling.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied Hypertensive vascular remodeling (n=96). Estradiol (E2) vs. Vehicle (Ovariectomized SHRs) was evaluated on Blood pressure and aortic medial thickness (vascular remodeling) (p=<0.0001). Estradiol supplementation significantly reduced blood pressure and attenuated vascular remodeling in ovariectomized spontaneously hypertensive rats by promoting ERα-mediated autophagic degradation of GRK2.
Synapse has enriched 10 related papers. Consider them for comparative context: